4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000253
EVP CLO & General Counsel sold 13,441 shares at an average $69.74 ($937,338)
- EVP CLO & General Counsel acquired 10,200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'NEIL PATRICK R. · EVP CLO & General Counsel
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,200 | $52.87 | $539,274 | 67,330 | D |
| 2025-10-06 | Sale : show line 2 in the form 10b5-1 | −10,200 | $69.89 | $712,849 | 57,130 | D |
| 2025-10-06 | Sale : show line 3 in the form 10b5-1 | −3,241 | $69.27 | $224,488 | 53,889 | D |
| Open-market sales · 13,441 sh · avg $69.74 · $937,338 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-06 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −10,200 | 17,000 | D |
Loading xslF345X05/edgardoc.xml…